A rapid assessment of take-home naloxone provision during COVID-19 in Europe

BACKGROUND: In March 2020, the World Health Organization declared COVID-19 a global pandemic. In the following weeks, most European countries implemented national lockdowns to mitigate viral spread. Services for people who use drugs had to quickly revise their operating procedures to rearrange servi...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Rebecca, Eide, Desiree, Abel-Ollo, Katri, Barnsdale, Lee, Carter, Ben, Clausen, Thomas, Day, Ed, Fonseca, Francina, Holmén, Elin, Horsburgh, Kirsten, Kelleher, Mike, Kåberg, Martin, Ladenhauf, Martin, McAuley, Andrew, Metrebian, Nicola, Neale, Joanne, Parkin, Stephen, Ratcliffe, Kevin, Rintoul, Chris, Smith, Josie, Stifanoviciute, Viktorija, Torrens, Marta, Thiesen, Henrik, Strang, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247228/
https://www.ncbi.nlm.nih.gov/pubmed/35849935
http://dx.doi.org/10.1016/j.drugpo.2022.103787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247228/
https://www.ncbi.nlm.nih.gov/pubmed/35849935
http://dx.doi.org/10.1016/j.drugpo.2022.103787

Ejemplares similares